Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France

Author： Bezin J.   Pariente A.   Lassalle R.   Dureau-Pournin C.   Abouelfath A.   Robinson P.   Moore N.   Droz-Perroteau C.   Fourrier-Reglat A.  

Publisher： Springer Publishing Company

ISSN： 0031-6970

Source： European Journal of Clinical Pharmacology, Vol.70, Iss.4, 2014-04, pp. : 429-436

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Secondary preventive drug use for acute coronary syndromes in France

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 380, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes

By Kassab Yaman  

International Journal of Clinical Pharmacy, Vol. 35, Iss. 2, 2013-04 ,pp. : 275-280

Springer Publishing Company

Access to resources Recommend Favorite

Prednisolone/tacrolimus: First report of acute coronary syndrome secondary to spontaneous coronary artery dissection: case report

By  

Reactions Weekly, Vol. 1, Iss. 1422, 2012-01 ,pp. : 39-39

Adis International

Access to resources Recommend Favorite

Secondary prevention after acute MI

By  

Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analysis of Enoxaparin versus Unfractionated Heparin in the Secondary Prevention of Acute Coronary Syndrome

By Brosa M.  

PharmacoEconomics, Vol. 20, Iss. 14, 2002-01 ,pp. : 979-987

Adis International

Access to resources Recommend Favorite